Академический Документы
Профессиональный Документы
Культура Документы
pursuing a vision to strengthen and advance the field of drug discovery and development in
the country. It is planning to initiate Phase I Clinical Trials of its lead molecules.The Institute
wishes to outsource cGMP manufacture of these Investigational New Drugs (IND-APIs) and
their oral formulations(tablets/capsules) in market-intended packaging; for the purpose of
“testing, analysis and clinical trials” conforming to the New Drugs and Clinical Trial Rules
2019 and The Drugs and Cosmetics Act 1940 and Rules 1945 as amended.
This Expression of Interest (EOI) invites applications for empanelment of Service Providers
with a proven track record in providing one or more of the services listed below:
The scope of work includes cGMP manufacturing of API and / or formulation of identified
CDRI lead compounds for testing, analysis and clinical trials; generation of Chemical and
Pharmaceutical Information for obtaining regulatory approvals. Interested Firmswith relevant
experience may please sign a Confidential Data Disclosure Agreement with CSIR-CDRI for
obtaining details of the API (such asKey Starting Materials and process of synthesis on
laboratory scale), and suggested dosage forms (excipients, processes).
The applicant should meet the following pre-qualification criteria given below and is required
to submit all supporting documents relating to the credentials / technical capabilities and
track record along with their EOI.
b) List of similar work / services provided successfully with minimum 2 years experience
in CSIR labs, Government organizations other than CSIR and to Private Agencies
along with brief details of the work. Enclose relevant document / certificate to
ascertain the satisfactory completion of the work / service provided.
Applications in response to this EOI should be submitted online as per prescribed format at
www.etenders.gov.in. The details of this EOI notice is also available on institute website
(www.cdri.res.in).